Showing results (1971-1980 of 2,378) with videos related to
Sort By:
Pageof 238
Expert Review of Cardiovascular Therapy|November 23, 2017
Cardiovascular complications of multiple myeloma in the elderlyPankaj Mathur, Sharmilan Thanendrarajan, Hakan Paydak, et al.Expert Review of Cardiovascular Therapy|July 31, 2021
Characteristics and hospital outcomes of coronary atherectomy within the United States: a multivariate and propensity-score matched analysisFahed Darmoch, Waqas Ullah, Yasser Al-Khadra, et al.Expert Review of Cardiovascular Therapy|November 14, 2018
Neurological complications associated with left ventricular assist device therapyKevin Goodwin, Austin Kluis, Tamas Alexy, et al.Expert Review of Cardiovascular Therapy|October 27, 2016
The role of multi modality imaging in selecting patients and guiding lead placement for the delivery of cardiac resynchronization therapyJonathan M Behar, Simon Claridge, Tom Jackson, et al.Expert Review of Cardiovascular Therapy|December 17, 2016
Does the evidence really suggest that we should completely revascularise bystander disease in patients with ST elevation myocardial infarction undergoing primary angioplasty? Why we still need more definitive trial data to change routine practiceMark Mariathas, Bartosz Olechowski, Michael Mahmoudi, et al.Expert Review of Cardiovascular Therapy|December 22, 2007
Ezetimibe plus simvastatin cardiovascular outcomes study programLuis Rodríguez PadialExpert Review of Cardiovascular Therapy|December 22, 2007
Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality managementKatherine W Phillips, Jack AnsellExpert Review of Cardiovascular Therapy|December 22, 2007
New insights and therapeutics for immune-mediated thrombocytopeniaAra Metjian, Charles S AbramsExpert Review of Cardiovascular Therapy|December 22, 2007
Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitusJithendra B Somaratne, Gillian A Whalley, Warwick Bagg, et al.Expert Review of Cardiovascular Therapy|February 6, 2008
Acarbose: oral anti-diabetes drug with additional cardiovascular benefitsMarkolf Hanefeld, Frank SchaperPageof 238